2. Academic Validation
  3. Targeting the KRAS G12D Mutant as Potential Therapy in Cancer

Targeting the KRAS G12D Mutant as Potential Therapy in Cancer

  • ACS Med Chem Lett. 2021 Aug 2;12(8):1212-1213. doi: 10.1021/acsmedchemlett.1c00390.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
PMID: 34413947 DOI: 10.1021/acsmedchemlett.1c00390
Figures